Most-Downgraded StocksMost-DowngradedNYSE:BSX Boston Scientific (BSX) Stock Price, News & Analysis $44.72 +0.10 (+0.21%) Closing price 03:59 PM EasternExtended Trading$44.80 +0.08 (+0.19%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Boston Scientific Stock (NYSE:BSX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Boston Scientific alerts:Sign Up Key Stats Today's Range$44.46▼$45.1650-Day Range$43.00▼$52.0252-Week Range$42.20▼$105.65Volume17.30 million shsAverage Volume21.14 million shsMarket Capitalization$64.80 billionP/E Ratio18.10Dividend YieldN/APrice Target$70.19Consensus RatingModerate Buy Company Overview Boston Scientific Corporation is a medical device company that develops, manufactures and markets products used in minimally invasive procedures. Its technologies are designed to diagnose and treat a range of medical conditions while supporting less invasive alternatives to traditional surgery. The company’s products address cardiovascular, endoscopy, urology, pelvic health and neuromodulation applications. Its portfolio includes devices used in cardiac rhythm management and electrophysiology, structural heart procedures, peripheral and vascular interventions, gastrointestinal procedures, kidney stone and prostate treatments, and therapies for chronic pain and other neurological conditions. Founded in 1979, Boston Scientific serves healthcare providers and patients in markets around the world. The company is headquartered in Marlborough, Massachusetts, and operates through a global network of research, manufacturing, sales and distribution facilities.AI Generated. May Contain Errors. Read More Boston Scientific Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks95th Percentile Overall ScoreBSX MarketRank™: Boston Scientific scored higher than 95% of companies evaluated by MarketBeat, and ranked 19th out of 901 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.3 / 5Analyst RatingModerate Buy Consensus RatingBoston Scientific has received a consensus rating of Moderate Buy. The company's average rating score is 2.68, and is based on no strong buy ratings, 23 buy ratings, 6 hold ratings, and 2 sell ratings.Upside PotentialBoston Scientific has a consensus price target of $70.19, representing about 57.0% upside from its current price of $44.72.Amount of Analyst CoverageBoston Scientific has been the subject of 15 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Boston Scientific's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth3.98% Earnings GrowthEarnings for Boston Scientific are expected to grow by 3.98% in the coming year, from $3.27 to $3.40 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Boston Scientific is 18.10, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.94.Price to Earnings Ratio vs. SectorThe P/E ratio of Boston Scientific is 18.10, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.98.Price to Earnings Growth RatioBoston Scientific has a PEG Ratio of 1.07. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioBoston Scientific has a P/B Ratio of 2.71. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Boston Scientific's valuation and earnings. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.22% of the float of Boston Scientific has been sold short.Short Interest Ratio / Days to CoverBoston Scientific has a short interest ratio ("days to cover") of 2.35, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Boston Scientific has recently decreased by 3.46%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldBoston Scientific does not currently pay a dividend.Dividend GrowthBoston Scientific does not have a long track record of dividend growth. News and Social Media2.2 / 5News Sentiment0.53 News SentimentBoston Scientific has a news sentiment score of 0.53. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.News Coverage This WeekMarketBeat has tracked 8 news articles for Boston Scientific this week, compared to 9 articles on an average week.Search Interest92 people have searched for BSX on MarketBeat in the last 30 days. This is an increase of 5% compared to the previous 30 days.MarketBeat FollowsOnly 25 people have added Boston Scientific to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Company Ownership4.3 / 5Insider TradingAcquiring Shares Cluster Insider Buying3 insiders have purchased shares of Boston Scientific in the last three months. Multiple insiders buying is a strong bullish signal.Net Insider BuyingOver the last three months, insiders have purchased a net $9,385,210.00 in company stock, which represents 0.0145% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, Boston Scientific insiders have bought more of their company's stock than they have sold. Specifically, they have bought $9,385,210.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders0.34% of the stock of Boston Scientific is held by insiders.Percentage Held by Institutions89.07% of the stock of Boston Scientific is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Boston Scientific's insider trading history. Receive BSX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Boston Scientific and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BSX Stock News HeadlinesBoston Scientific (BSX) stock moves 2.74%: What you should knowSeptember 23 at 9:25 AM | msn.comBoston Scientific Announces Retirement of MedSurg, Asia Pacific ChiefSeptember 23 at 6:31 AM | tipranks.comMILLIONAIRE MASTERCLASS INVITE: AltucherJames Altucher says Elon Musk is preparing an unprecedented project set to surface on September 25. Altucher is hosting a free masterclass revealing what he says is locked inside a sealed briefcase detailing Musk's plans. Attendees who join early can also access a $1,000 bonus offer included with the presentation.September 24 at 1:00 AM | Paradigm Press (Ad)How Far Can BSX Stock Swing After Losing More Than Half Its Value?September 22 at 2:38 PM | finance.yahoo.comAnalyst Maintains Buy on Boston Scientific, Viewing Cyberattack Impact as Short-Lived Despite Trimmed Near-Term ForecastsSeptember 18, 2026 | tipranks.comBoston Scientific downgraded at Citi on increasing competition, cyberattack falloutSeptember 17, 2026 | seekingalpha.comWhy BSX Stock Lost More Than Half Its Value While Sales Kept RisingSeptember 17, 2026 | finance.yahoo.comBoston Scientific (BSX) Stock Trades At A Discount On A 55% SlumpSeptember 17, 2026 | finance.yahoo.comSee More Headlines BSX Stock Analysis - Frequently Asked Questions How have BSX shares performed this year? Boston Scientific's stock was trading at $95.29 at the start of the year. Since then, BSX stock has decreased by 53.1% and is now trading at $44.7150. How were Boston Scientific's earnings last quarter? Boston Scientific Corporation (NYSE:BSX) released its quarterly earnings data on Wednesday, July, 29th. The medical equipment provider reported $0.86 EPS for the quarter, topping analysts' consensus estimates of $0.83 by $0.03. Boston Scientific's revenue for the quarter was up 7.5% on a year-over-year basis. Read the conference call transcript. Is Boston Scientific buying back stock? Boston Scientific's Board of Directors approved a stock buyback program on Monday, May 18th 2026, which permits the company to buy back $5,000,000,000 in shares, according to EventVestor. This means that the company could repurchase up to 6.4% of its shares through open market purchases. Shares buyback programs are generally a sign that the company's board believes its shares are undervalued. Does Boston Scientific have any subsidiaries? Boston Scientific subsidiaries include VertiFlex, BTG, Augmenix, Veniti, Claret Medical, Cryterion Medical, nVision Medical, and others. Who are Boston Scientific's major shareholders? Top institutional investors of Boston Scientific include BlackRock Inc. (8.95%), Primecap Management Co. CA (3.49%), Jupiter Topco LLC (1.30%) and Wellington Management Group LLP (1.06%). Insiders that own company stock include Michael F Mahoney, Daniel J Brennan, Joseph Michael Fitzgerald, Vance R Brown, Eric Francis Yves Thepaut, Edward J Ludwig, Edward J Ludwig, Wendy Carruthers, Jeffrey B Mirviss, Ellen M Zane, Arthur C Butcher, John Bradley Sorenson, David C Habiger, Yoshiaki Fujimori, Cheryl Pegus and Charles J Dockendorff. View institutional ownership trends. How do I buy shares of Boston Scientific? Shares of BSX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Boston Scientific own? Based on aggregate information from My MarketBeat watchlists, some other companies that Boston Scientific investors own include BlackRock (BLK), Broadcom (AVGO), ServiceNow (NOW), UnitedHealth Group (UNH), The Goldman Sachs Group (GS), NVIDIA (NVDA) and Illinois Tool Works (ITW). Company Calendar Last Earnings7/29/2026Today9/24/2026Next Earnings (Estimated)10/28/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (2w+) 1-Year History Sep 25 Dec 25 Mar 26 Jun 26 Sep 26 For the last 2 weeks, BSX's financial health has been in the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNYSE:BSX CIK885725 Webwww.bostonscientific.com Phone(508) 683-4000Fax508-683-5675Employees59,000Year Founded1979Price Target and Rating Average Price Target for Boston Scientific$70.19 High Price Target$118.00 Low Price Target$48.00 Potential Upside/Downside+57.0%Consensus RatingModerate Buy Rating Score (0-4)2.68 Research Coverage31 Analysts Profitability EPS (Trailing Twelve Months)$2.47 Trailing P/E Ratio18.10 Forward P/E Ratio13.67 P/E Growth1.07Net Income$2.90 billion Net Margins17.50% Pretax Margin18.39% Return on Equity19.28% Return on Assets10.89% Debt Debt-to-Equity Ratio0.43 Current Ratio1.24 Quick Ratio0.74 Sales & Book Value Annual Sales$20.07 billion Price / Sales3.23 Cash Flow$4.02 per share Price / Cash Flow11.13 Book Value$16.49 per share Price / Book2.71Miscellaneous Outstanding Shares1,449,230,000Free Float1,444,303,000Market Cap$64.80 billion OptionableOptionable Beta0.57 Social Links The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (NYSE:BSX) was last updated on 9/24/2026 by MarketBeat.com Staff. From Our PartnersA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredShocking new footage just releasedGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredThe retirement stock I'd buy before Nvidia todayIn 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Ch...Chaikin Analytics | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredHow to get a stake in Anthropic — before the IPOAnthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as October. Its ...Weiss Ratings | SponsoredIf you keep cash in a U.S. bank account… read this NOWSince 2020, U.S. banks have been required to keep zero percent of deposits on hand, lending out nearly every d...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Boston Scientific Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Boston Scientific With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
